MUC16 and ovarian cancer: The evaluation of recurrence and metastasis mainly relies on CA125 and CT, but CA125 and CT cannot monitor dynamically and timely the situation of ovarian cancer patients after recurrence, and the detection of metastatic lesions is also limited.